<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1342" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1342/" /><meta name="ncbi_pagename" content="Cockayne Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Cockayne Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Cockayne Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/08/29" /><meta name="citation_author" content="Vincent Laugel" /><meta name="citation_pmid" content="20301516" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1342/" /><meta name="citation_keywords" content="Cockayne Syndrome Type II" /><meta name="citation_keywords" content="Cockayne Syndrome Type I" /><meta name="citation_keywords" content="Cockayne Syndrome Type III" /><meta name="citation_keywords" content="Cerebrooculofacioskeletal (COFS) Syndrome" /><meta name="citation_keywords" content="DNA excision repair protein ERCC-6" /><meta name="citation_keywords" content="DNA excision repair protein ERCC-8" /><meta name="citation_keywords" content="ERCC6" /><meta name="citation_keywords" content="ERCC8" /><meta name="citation_keywords" content="Cockayne Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Cockayne Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Vincent Laugel" /><meta name="DC.Date" content="2019/08/29" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1342/" /><meta name="description" content="Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes:" /><meta name="og:title" content="Cockayne Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1342/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cockayne/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1342/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88B316E04075D10000000006B10295.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1342_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1342_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ccd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cls/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1342_"><span class="title" itemprop="name">Cockayne Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Vincent Laugel</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1342_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1342_ai__"><div class="contrib half_rhythm"><span itemprop="author">Vincent Laugel</span>, MD, PhD<div class="affiliation small">Laboratory of Medical Genetics<br />Strasbourg, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.gruobsarts-urhc@legual.tnecniv" class="oemail">rf.gruobsarts-urhc@legual.tnecniv</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 28, 2000</span>; Last Update: <span itemprop="dateModified">August 29, 2019</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cockayne.Summary" itemprop="description"><h2 id="_cockayne_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Cockayne syndrome (referred to as CS in this <i>GeneReview</i>) spans a continuous phenotypic spectrum that includes:</p><ul><li class="half_rhythm"><div>CS type I, the "classic" or "moderate" form;</div></li><li class="half_rhythm"><div>CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome;</div></li><li class="half_rhythm"><div>CS type III, a milder and later-onset form;</div></li><li class="half_rhythm"><div>COFS syndrome, a fetal form of CS.</div></li></ul><p>CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade.</p><p>CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years.</p><p>CS type III is a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I.</p><p>COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Cockayne syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ERCC6</i> or <i>ERCC8</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Feeding gastrostomy tube placement as needed; individualized educational programs for developmental delay; medications for tremor and spasticity as needed; physical therapy to prevent contractures; use of sunglasses for lens/retina protection; treatment of cataracts, and other ophthalmologic complications, hearing loss, hypertension, and gastroesophageal reflux as in the general population. Aggressive dental care to minimize dental caries; use of sunscreens and limitation of sun exposure for cutaneous photosensitivity.</p><p><i>Surveillance:</i> Biannual assessment of diet, nervous system, and ophthalmologic status. Yearly assessment for complications such as hearing loss, hepatic or renal dysfunction, and hypertension.</p><p><i>Agents/circumstances to avoid:</i> Excessive sun exposure and use of metronidazole. Extra vigilance is needed for opioid and sedative use. Use of growth hormone treatment is not recommended in those with CS.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Cockayne syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives, prenatal testing for pregnancies at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the <i>ERCC6</i> or <i>ERCC8</i> pathogenic variants in the family are known.</p></div></div><div id="cockayne.GeneReview_Scope"><h2 id="_cockayne_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="cockayne.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1342/table/cockayne.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cockayne.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cockayne.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cockayne Syndrome (CS): Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_cockayne.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>CS type I</div></li><li class="half_rhythm"><div>CS type II</div></li><li class="half_rhythm"><div>CS type III</div></li><li class="half_rhythm"><div>Cerebrooculofacioskeletal (COFS) syndrome</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#cockayne.Nomenclature">Nomenclature</a>.</p></div></dd></dl></div></div></div></div><div id="cockayne.Diagnosis"><h2 id="_cockayne_Diagnosis_">Diagnosis</h2><p>Cockayne syndrome (CS) is characterized by growth failure and multisystemic involvement, with a variable age of onset and rate of progression. To facilitate clinical recognition and follow up, the phenotypic spectrum of CS can be divided into different clinical presentations. Note, however, that among all individuals with CS there is a continuous spectrum of clinical severities without clear thresholds and that intermediate phenotypes may arise:</p><ul><li class="half_rhythm"><div><b>Cockayne syndrome type I,</b> "classic" CS, in which the major features of the disease become apparent by age one to two years</div></li><li class="half_rhythm"><div><b>Cockayne syndrome type II,</b> a more severe form with abnormalities recognized at birth or in the early neonatal period</div></li><li class="half_rhythm"><div><b>Cockayne syndrome type III,</b> milder/later-onset forms in which major features only become apparent after age two years</div></li><li class="half_rhythm"><div><b>Cerebrooculofacioskeletal (COFS) syndrome,</b> very severe fetal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with arthrogryposis, prenatal growth failure, prenatal microcephaly, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts or microphthalmia</div></li></ul><p>Formal clinical diagnostic criteria originally proposed for CS type I [<a class="bk_pop" href="#cockayne.REF.nance.1992.68">Nance &#x00026; Berry 1992</a>] have been revised and extended in more recent publications [<a class="bk_pop" href="#cockayne.REF.natale.2011.1081">Natale 2011</a>, <a class="bk_pop" href="#cockayne.REF.laugel.2013.161">Laugel 2013</a>]. Because of the progressive nature of CS, the clinical diagnosis becomes more certain as additional signs and symptoms gradually manifest over time.</p><div id="cockayne.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Cockayne syndrome <b>should be suspected</b> in individuals with the following findings.</p><p><b>Major criteria</b></p><ul><li class="half_rhythm"><div>Postnatal growth failure (height and weight &#x0003c;5th centile by age 2 years)</div></li><li class="half_rhythm"><div>Progressive microcephaly and neurologic dysfunction manifested as early developmental delay in most individuals, followed by progressive behavioral and intellectual deterioration in all individuals; brain MRI reveals white matter dysmyelination and cerebellar atrophy [<a class="bk_pop" href="#cockayne.REF.koob.2010.1623">Koob et al 2010</a>, <a class="bk_pop" href="#cockayne.REF.koob.2016.20151033">Koob et al 2016</a>]. Intracranial calcifications (mainly located in the basal ganglia) are seen in some individuals.</div></li></ul><p><b>Minor criteria</b></p><ul><li class="half_rhythm"><div>Cutaneous photosensitivity</div></li><li class="half_rhythm"><div>Demyelinating peripheral neuropathy diagnosed by nerve conduction testing</div></li><li class="half_rhythm"><div>Pigmentary retinopathy and/or cataracts</div></li><li class="half_rhythm"><div>Sensorineural hearing loss</div></li><li class="half_rhythm"><div>Dental anomalies including dental caries, enamel hypoplasia, and anomalies of tooth number and tooth size and shape</div></li><li class="half_rhythm"><div>A characteristic physical appearance of "cachectic dwarfism" with sunken eyes</div></li></ul><p><b>CS type I (classic)</b> is suspected:</p><ul><li class="half_rhythm"><div>In an older child when both major criteria are present and three minor criteria are present;</div></li><li class="half_rhythm"><div>In an infant or toddler when both major criteria are present, especially if there is increased cutaneous photosensitivity.</div></li></ul><p><b>CS type II (severe)</b> is suspected:</p><ul><li class="half_rhythm"><div>In infants with growth failure at birth and little postnatal increase in height, weight, or head circumference;</div></li><li class="half_rhythm"><div>When there is little or no postnatal neurologic development;</div></li><li class="half_rhythm"><div>When <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts are present.</div></li></ul><p><b>CS Type III (mild)</b> is suspected:</p><ul><li class="half_rhythm"><div>In children or teenagers with short stature, mild neurologic impairment, and progressive ataxia;</div></li><li class="half_rhythm"><div>Especially but not exclusively when there is cutaneous photosensitivity.</div></li></ul><p><b>COFS syndrome</b> is suspected when prenatal growth failure and prenatal microcephaly are associated with arthrogryposis and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts as well as other structural defects of the eye (microphthalmos, microcornea, iris hypoplasia).</p></div><div id="cockayne.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Cockayne syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ERCC6</i> or <i>ERCC8</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1342/table/cockayne.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figcockayneTmoleculargenetictestinguse" rid-ob="figobcockayneTmoleculargenetictestinguse">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis, <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Cockayne syndrome is broad, individuals with the distinctive findings described in <a href="#cockayne.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#cockayne.Option_1">Option 1</a>), whereas those in whom the diagnosis of Cockayne syndrome has not been considered are more likely to be diagnosed using genomic testing (see <a href="#cockayne.Option_2">Option 2</a>).</p><div id="cockayne.Option_1"><h4>Option 1</h4><p>When the phenotypic findings suggest the diagnosis of Cockayne syndrome the recommended <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approach is to use a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ERCC6</i>, <i>ERCC8</i>, and other genes of interest (see <a href="#cockayne.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For this disorder a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that also includes <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is recommended (see <a class="figpopup" href="/books/NBK1342/table/cockayne.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figcockayneTmoleculargenetictestinguse" rid-ob="figobcockayneTmoleculargenetictestinguse">Table 1</a>).</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="cockayne.Option_2"><h4>Option 2</h4><p>When the diagnosis of Cockayne syndrome is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="cockayne.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Cockayne Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1342/table/cockayne.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cockayne.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of Cockayne Syndrome Attributed to Pathogenic Variants in Gene</th><th id="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Method</th></tr><tr><th headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_3" id="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_3" id="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC6</i></td><td headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~65%</td><td headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_3 hd_h_cockayne.T.molecular_genetic_testing_use_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%<sup>6</sup></td><td headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_3 hd_h_cockayne.T.molecular_genetic_testing_use_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC8</i></td><td headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~35%</td><td headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_3 hd_h_cockayne.T.molecular_genetic_testing_use_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">88%&#x000a0;<sup>6</sup></td><td headers="hd_h_cockayne.T.molecular_genetic_testing_use_1_1_1_3 hd_h_cockayne.T.molecular_genetic_testing_use_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cockayne.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="cockayne.TF.1.2"><p class="no_margin">See <a href="/books/NBK1342/#cockayne.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="cockayne.TF.1.3"><p class="no_margin">See <a href="#cockayne.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="cockayne.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="cockayne.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="cockayne.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#cockayne.REF.laugel.2010.113">Laugel et al [2010]</a>, <a class="bk_pop" href="#cockayne.REF.calmels.2018.329">Calmels et al [2018]</a></p></div></dd></dl></div></div></div></div><div id="cockayne.DNA_Repair_Assay"><h4>DNA Repair Assay</h4><p>If the diagnosis of Cockayne syndrome is strongly suspected, but the <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> does not identify pathogenic variants in one of the associated genes, an assay of the cellular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> can be considered.</p><p>Assays of DNA repair are performed on skin fibroblasts. The most consistent findings in CS fibroblasts are marked sensitivity to UV radiation and deficient recovery of RNA synthesis following UV damage (i.e., impaired repair of actively transcribed genes, or "transcription-coupled repair") [<a class="bk_pop" href="#cockayne.REF.nakazawa.2010.506">Nakazawa et al 2010</a>].</p></div></div></div><div id="cockayne.Clinical_Characteristics"><h2 id="_cockayne_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cockayne.Clinical_Description"><h3>Clinical Description</h3><p>Before the molecular genetics of Cockayne syndrome was understood, it was thought to have a single, discrete <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>: classic Cockayne syndrome. It is now recognized that Cockayne syndrome spans a continuous phenotypic spectrum without clear thresholds, and includes the following [<a class="bk_pop" href="#cockayne.REF.nance.1992.68">Nance &#x00026; Berry 1992</a>]:</p><ul><li class="half_rhythm"><div>CS type I, the "classic" form</div></li><li class="half_rhythm"><div>CS type II, a more severe form with symptoms present at birth (overlapping with cerebrooculofacioskeletal syndrome [COFS])</div></li><li class="half_rhythm"><div>CS type III, a milder form</div></li><li class="half_rhythm"><div>Cerebrooculofacioskeletal (COFS) syndrome, the most severe end of the phenotypic spectrum of CS with findings identifiable during fetal life</div></li></ul><div id="cockayne.CS_Type_I"><h4>CS Type I</h4><p><b>Presentation</b>. Prenatal growth is typically normal. Birth length, weight, and head circumference are normal. Within the first two years, however, growth and development fall below normal. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile.</p><p><b>Progression.</b> Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability. Brain MRI reveals white matter dysmyelination and progressive cerebral and cerebellar atrophy. Photosensitivity is variable, but individuals are not predisposed to skin cancers.</p><p><b>Additional clinical abnormalities</b> occurring in 10% or more of individuals include the following:</p><ul><li class="half_rhythm"><div><b>Neurologic.</b> Increased tone/spasticity, hyper- or hyporeflexia, stooped standing posture, abnormal gait or inability to walk, ataxia, incontinence, tremor, abnormal or absent speech, seizures, weak cry / poor feeding (as an infant), muscle atrophy, and behavior abnormality</div></li><li class="half_rhythm"><div><b>Dermatologic.</b> Anhidrosis, malar rash, thin dry hair [<a class="bk_pop" href="#cockayne.REF.frouin.2013.1414">Frouin et al 2013</a>]</div></li><li class="half_rhythm"><div><b>Ophthalmologic.</b> Enophthalmos, pigmentary retinopathy (60%-100%), abnormal electroretinogram, cataracts of various types (15%-36%), optic atrophy, miotic pupils, farsightedness, decreased or absent tears, strabismus, nystagmus, photophobia, narrowed retinal arterioles</div></li><li class="half_rhythm"><div><b>Hearing</b>. Sensorineural hearing loss</div></li><li class="half_rhythm"><div><b>Dental.</b> Absent or hypoplastic teeth, enamel hypoplasia, delayed eruption of deciduous teeth, and malocclusion. Enamel anomalies frequently lead to severe dental caries [<a class="bk_pop" href="#cockayne.REF.blochzupan.2013.9">Bloch-Zupan et al 2013</a>].</div></li><li class="half_rhythm"><div><b>Skeletal.</b> Radiographic findings of thickened calvarium (due to microcephaly), sclerotic epiphyses, vertebral and pelvic abnormalities</div></li><li class="half_rhythm"><div><b>Renal.</b> Abnormal renal function, proteinuria, nephrotic syndrome, hyperuricemia, hypertension [<a class="bk_pop" href="#cockayne.REF.sterndelfils.2019">Stern-Delfils et al 2019</a>]</div></li><li class="half_rhythm"><div><b>Endocrine.</b> Undescended testes, delayed/absent sexual maturation, diabetes</div></li><li class="half_rhythm"><div><b>Gastrointestinal.</b> Elevated liver function tests, enlargement of liver or spleen, gastroesophageal reflux</div></li></ul><p>Death typically occurs in the first or second decade. The mean age of death is 16 years, although survival into the third decade has been reported [<a class="bk_pop" href="#cockayne.REF.natale.2011.1081">Natale 2011</a>].</p></div><div id="cockayne.CS_Type_II"><h4>CS Type II</h4><p>Children with severe CS have evidence of growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye are present in 30%. Affected individuals may have some contractures of the spine (kyphosis, scoliosis) and joints in neonatal or early postnatal life. Affected children typically die by age five years [<a class="bk_pop" href="#cockayne.REF.natale.2011.1081">Natale 2011</a>]. CS type II partly overlaps with cerebrooculofacioskeletal (COFS) syndrome.</p></div><div id="cockayne.CS_Type_III"><h4>CS Type III</h4><p>DNA sequencing has confirmed the diagnosis of CS type III in some individuals who have clinical features associated with CS but whose growth and/or cognition exceeds the expectations for CS type I [<a class="bk_pop" href="#cockayne.REF.natale.2011.1081">Natale 2011</a>, <a class="bk_pop" href="#cockayne.REF.baez.2013.80">Baez et al 2013</a>]. Major features only become apparent after age two years.</p></div><div id="cockayne.COFS_Syndrome"><h4>COFS Syndrome</h4><p>COFS syndrome is the most severe subtype of the CS spectrum and can be identified during fetal life. Similarly to individuals with CS type II, individuals with COFS syndrome present with severe prenatal growth failure, severe developmental delay / intellectual disability from birth, axial hypotonia, peripheral hypertonia, and neonatal feeding difficulties. COFS syndrome is additionally defined by the presence of arthrogryposis and usually the combination of extreme <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> microcephaly and congenital cataracts [<a class="bk_pop" href="#cockayne.REF.laugel.2008.564">Laugel et al 2008</a>].</p><p><b>Neuropathology.</b> In all forms of Cockayne syndrome, a characteristic "tigroid" pattern of demyelination in the subcortical white matter of the brain and multifocal calcium deposition, with relative preservation of neurons and without senile plaques, amyloid, ubiquitin, or tau deposition, has been observed together with arteriosclerosis [<a class="bk_pop" href="#cockayne.REF.weidenheim.2009.619">Weidenheim et al 2009</a>, <a class="bk_pop" href="#cockayne.REF.hayashi.2012.113">Hayashi et al 2012</a>].</p></div></div><div id="cockayne.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>To date no <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> for <i>ERCC6</i> or <i>ERCC8</i> have been clearly identified.</p></div><div id="cockayne.Nomenclature"><h3>Nomenclature</h3><p>The term cerebrooculofacioskeletal (COFS) syndrome and its former synonym, Pena-Shokeir syndrome type II, have been used to refer to a heterogeneous group of disorders characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neurogenic arthrogryposis (multiple joint contractures), microcephaly, microphthalmia, and cataracts. The original cases of COFS syndrome, described by <a class="bk_pop" href="#cockayne.REF.pena.1974.285">Pena &#x00026; Shokeir [1974]</a> among native Canadian families from Manitoba, have since been shown to be <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ERCC6</i>. COFS syndrome is now regarded as an allelic and prenatal form of CS, partly overlapping with CS type II and including the most severe cases of the CS phenotypic spectrum [<a class="bk_pop" href="#cockayne.REF.laugel.2008.564">Laugel et al 2008</a>].</p></div><div id="cockayne.Prevalence"><h3>Prevalence</h3><p>The minimum incidence of CS has been estimated at 2.7 per million births in western Europe; the disease is probably underdiagnosed [<a class="bk_pop" href="#cockayne.REF.kleijer.2008.744">Kleijer et al 2008</a>].</p></div></div><div id="cockayne.Genetically_Related_Allelic_Dis"><h2 id="_cockayne_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p>Other phenotypes associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>ERCC6</i> and <i>ERCC8</i> are summarized in <a class="figpopup" href="/books/NBK1342/table/cockayne.T.allelic_disorders/?report=objectonly" target="object" rid-figpopup="figcockayneTallelicdisorders" rid-ob="figobcockayneTallelicdisorders">Table 2</a>.</p><div id="cockayne.T.allelic_disorders" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Allelic Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1342/table/cockayne.T.allelic_disorders/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cockayne.T.allelic_disorders_lrgtbl__"><table><thead><tr><th id="hd_h_cockayne.T.allelic_disorders_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_cockayne.T.allelic_disorders_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_cockayne.T.allelic_disorders_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th></tr></thead><tbody><tr><td headers="hd_h_cockayne.T.allelic_disorders_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC6</i></td><td headers="hd_h_cockayne.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">UV-sensitive syndrome 1</td><td headers="hd_h_cockayne.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cockayne.REF.horibata.2004.15410">Horibata et al [2004]</a></td></tr><tr><td headers="hd_h_cockayne.T.allelic_disorders_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Premature ovarian failure (reported in 1 study)</td><td headers="hd_h_cockayne.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cockayne.REF.qin.2015.e1005419">Qin et al [2015]</a></td></tr><tr><td headers="hd_h_cockayne.T.allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC8</i></td><td headers="hd_h_cockayne.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">UV-sensitive syndrome 2</td><td headers="hd_h_cockayne.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cockayne.REF.nardo.2009.6209">Nardo et al [2009]</a></td></tr></tbody></table></div></div></div><div id="cockayne.Differential_Diagnosis"><h2 id="_cockayne_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of Cockayne syndrome (CS) depends on the presenting features of the particular individual (see <a class="figpopup" href="/books/NBK1342/table/cockayne.T.disorders_to_consider_in_the/?report=objectonly" target="object" rid-figpopup="figcockayneTdisorderstoconsiderinthe" rid-ob="figobcockayneTdisorderstoconsiderinthe">Table 3</a>). Abnormalities that suggest alternative diagnoses include: <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies of the face, limbs, heart, or viscera; recurrent infections (other than otitis media or respiratory infections); metabolic or neurologic crises; hematologic abnormality (e.g., anemia, leukopenia); and cancer of any kind.</p><p>Growth failure is seen in <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> disorders and endocrine, metabolic, or gastrointestinal disorders, including malnutrition.</p><div id="cockayne.T.disorders_to_consider_in_the" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Cockayne Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1342/table/cockayne.T.disorders_to_consider_in_the/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cockayne.T.disorders_to_consider_in_the_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of Cockayne Syndrome</th></tr><tr><th headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4" id="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Also in differential diagnosis disorder</th><th headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4" id="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not in differential diagnosis disorder</th></tr></thead><tbody><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Connatal form of <a href="/books/n/gene/pmd/">Pelizaeus-Merzbacher disease</a>&#x000a0;<sup>1</sup></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLP1</i></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Growth failure</div></li><li class="half_rhythm"><div>Hypomyelination</div></li></ul></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Severe growth failure</div></li><li class="half_rhythm"><div>Distinctive physical appearance</div></li></ul></td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cdls/">Cornelia de Lange syndrome</a></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HDAC8</i><br /><i>NIPBL</i><br /><i>RAD21</i><br /><i>SMC1A</i><br /><i>SMC3</i></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />XL</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_1" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;">Profound growth failure</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_2" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;">Distinctive physical appearance</td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dubowitz syndrome (OMIM <a href="https://omim.org/entry/223370" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">223370</a>)</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">?</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">?</td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hallerman-Streiff syndrome (OMIM <a href="https://omim.org/entry/234100" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">234100</a>)</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">?</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">?</td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/rsts/">Rubinstein-Taybi syndrome</a></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CREBBP</i><br /><i>EP300</i></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/rss/">Silver-Russell syndrome</a></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2 hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">See footnote 2</td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seckel syndrome (OMIM <a href="https://omim.org/phenotypicSeries/PS210600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS210600</a>)</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~9 genes&#x000a0;<sup>3</sup></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Wiedemann-Rautenstrauch syndrome (OMIM <a href="https://omim.org/entry/264090" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">264090</a>)</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLR3A</i></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital infections (e.g., rubella or toxoplasmosis)</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_1" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Calcifications on brain imaging</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>White matter hypomyelination</div></li><li class="half_rhythm"><div>Distinctive physical appearance</div></li></ul></td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorders of calcium &#x00026; phosphate metabolism</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/xp/">Xeroderma pigmentosum</a></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9 genes&#x000a0;<sup>4</sup></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_1" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;">Prominent photosensitivity &#x00026;/or thinning of skin &#x00026; hair</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_2" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>White matter hypomyelination</div></li><li class="half_rhythm"><div>Brain calcifications</div></li><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Neurodegenerative features</div></li></ul></td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bloom/">Bloom syndrome</a></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BLM</i></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hgps/">Hutchinson-Gilford progeria syndrome</a></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMNA</i></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/werner/">Werner syndrome</a></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WRN</i></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/rts/">Rothmund-Thompson syndrome</a></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RECQL4</i></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mt-overview/">Mitochondrial disorders</a></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 5</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR<br />Mat</td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Early presence of pigmentary retinopathy</div></li><li class="half_rhythm"><div>Brain calcifications</div></li><li class="half_rhythm"><div>Neurodegeneration</div></li></ul></td><td headers="hd_h_cockayne.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cockayne.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Skin photosensitivity</div></li><li class="half_rhythm"><div>Distinctive physical appearance</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">? = unknown; AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; COFS = cerebrooculofacioskeletal syndrome; CS = Cockayne syndrome; Mat = maternal; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="cockayne.TF.3.1"><p class="no_margin">Most leukodystrophies are not associated with growth failure, with the possible exception of the connatal form of <a href="/books/n/gene/pmd/">Pelizaeus-Merzbacher disease</a>.</p></div></dd><dt>2. </dt><dd><div id="cockayne.TF.3.2"><p class="no_margin">Silver-Russell syndrome has multiple etiologies including: epigenetic changes that modify expression of genes in the <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> region of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15.5, maternal UPD7, and (infrequently) <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance.</p></div></dd><dt>3. </dt><dd><div id="cockayne.TF.3.3"><p class="no_margin"><i>ATR, CENPJ, CEP152, CEP63, DNA2, NIN, NSMCE2, RBBP8, TRAIP</i></p></div></dd><dt>4. </dt><dd><div id="cockayne.TF.3.4"><p class="no_margin"><i>DDB2, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, POLH, XPA, XPC</i></p></div></dd><dt>5. </dt><dd><div id="cockayne.TF.3.5"><p class="no_margin">Mitochondrial disorders can be caused by mutation of genes encoded by either nuclear DNA or mitochondrial DNA (see <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>).</p></div></dd></dl></div></div></div><p><b>Warburg micro syndrome</b> (OMIM <a href="https://omim.org/phenotypicSeries/PS600118" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS600118</a>), associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>RAB18</i>,<i>RAB3GAP1</i>, <i>RAB3GAP2</i>, or <i>TBC1D20</i> and presenting with microcephaly, microcornea, and cataracts, may resemble CS type II / COFS syndrome at birth. However; Warburg micro syndrome is not associated with rapidly progressive neurodegeneration and has normal DNA nucleotide excision repair [<a class="bk_pop" href="#cockayne.REF.graham.2004.235">Graham et al 2004</a>].</p></div><div id="cockayne.Management"><h2 id="_cockayne_Management_">Management</h2><div id="cockayne.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Cockayne syndrome (CS), the evaluations summarized in <a class="figpopup" href="/books/NBK1342/table/cockayne.T.recommended_evaluations_follo/?report=objectonly" target="object" rid-figpopup="figcockayneTrecommendedevaluationsfollo" rid-ob="figobcockayneTrecommendedevaluationsfollo">Table 4</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="cockayne.T.recommended_evaluations_follo" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with Cockayne Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1342/table/cockayne.T.recommended_evaluations_follo/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cockayne.T.recommended_evaluations_follo_lrgtbl__"><table><thead><tr><th id="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/<br />Concern</th><th id="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth</b></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Measure &#x00026; plot on standard growth charts.</div></li><li class="half_rhythm"><div>Assessment of feeding</div></li></ul></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Development</b></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>To incl motor, adaptive, cognitive &#x00026; speech/language evaluation</div></li><li class="half_rhythm"><div>Evaluation for early intervention / special education</div></li></ul></td></tr><tr><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Brain MRI</div></li><li class="half_rhythm"><div>Assessment of muscle tone &#x00026; for presence of contractures</div></li></ul></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Possibly incl electroretinogram.</td></tr><tr><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiologic evaluation</td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl audiogram.</td></tr><tr><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skin</b></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dermatologic evaluation</td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Teeth</b></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dental evaluation</td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal</b></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Radiographs to document skeletal dysplasia if suggestive clinical signs</td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Kidneys</b></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Laboratory evaluation of renal function</td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Liver</b></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Laboratory evaluation of liver function</td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_cockayne.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="cockayne.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="cockayne.T.treatment_of_manifestations_i" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Cockayne Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1342/table/cockayne.T.treatment_of_manifestations_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cockayne.T.treatment_of_manifestations_i_lrgtbl__"><table><thead><tr><th id="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Poor growth</b></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Feeding gastrostomy tube placement as needed</td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Avoid rapid &#x02191; in volume of feeds</td></tr><tr><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Developmental delay /</b><br /><b>Intellectual disability</b></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#cockayne.Developmental_Disability__Intel">Developmental Delay / Intellectual Disability Management Issues</a> in text following the table.</td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Tremor - spasticity</b></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Medication for tremor (carbidopa-levodopa [<a class="bk_pop" href="#cockayne.REF.neilan.2008.1117">Neilan et al 2008</a>]) &#x00026; spasticity (baclofen) if needed</div></li><li class="half_rhythm"><div>Physical therapy to prevent joint contractures</div></li><li class="half_rhythm"><div>Home safety assessments to prevent falls</div></li></ul></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Abnormal vision and/or cataracts</b></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Standard treatment(s) as per ophthalmologist</div></li><li class="half_rhythm"><div>Use of sunglasses for lens &#x00026; retina protection</div></li></ul></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing loss</b></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hearing aids may be helpful as per otolaryngologist.</div></li><li class="half_rhythm"><div>Cochlear implants may be used [<a class="bk_pop" href="#cockayne.REF.van_wyhe.2018.64">Van Wyhe et al 2018</a>].</div></li></ul></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dental caries</b></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Aggressive dental care to minimize caries</td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cutaneous photosensitivity</b></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Use of sunscreens; limitation of sun exposure</td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hypertension</b></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Amlodipine, ACE inhibitor</td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastroesophageal reflux</b></td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proton pump inhibitor</td><td headers="hd_h_cockayne.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div><div id="cockayne.Developmental_Disability__Intel"><h4>Developmental Disability / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy as well as infant mental health services, special educators, and sensory impairment specialists. In the US, early intervention is a federally funded program available in all states that provides in-home services to target individual therapy needs.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed for those who qualify based on established motor, language, social, or cognitive delay. The early intervention program typically assists with this transition. Developmental preschool is center based; for children too medically unstable to attend, home-based services are provided.</p><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies (US) and to support parents in maximizing quality of life. Some issues to consider:</p><ul><li class="half_rhythm"><div>IEP services:</div><ul><li class="half_rhythm"><div>An IEP provides specially designed instruction and related services to children who qualify.</div></li><li class="half_rhythm"><div>IEP services will be reviewed annually to determine if any changes are needed.</div></li><li class="half_rhythm"><div>As required by special education law, children should be in the least restricted environment feasible at school and included in general education as much as possible and when appropriate.</div></li><li class="half_rhythm"><div>Vision and hearing consultants should be a part of the child&#x02019;s IEP team to support access to academic material.</div></li><li class="half_rhythm"><div>PT, OT and speech services will be provided in the IEP to the extent that the need affects the child&#x02019;s access to academic material. Beyond that, private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual&#x02019;s needs may be considered. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</div></li><li class="half_rhythm"><div>As a child enters teen years, a transition plan should be discussed and incorporated in the IEP. For those receiving IEP services, the public school district is required to provide services until age 21.</div></li></ul></li><li class="half_rhythm"><div>A 504 plan (Section 504: a US federal statute that prohibits discrimination based on disability) can be considered for those who require accommodations or modifications such as front-of-class seating, assistive technology devices, classroom scribes, extra time between classes, modified assignments, and enlarged text.</div></li><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a US public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="cockayne.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., contractures, scoliosis, hip dislocation).</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment and positioning devices as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li><li class="half_rhythm"><div>For muscle tone abnormalities including hypertonia or dystonia, consider involving appropriate specialists to aid in management of baclofen, tizanidine, Botox<sup>&#x000ae;</sup>, anti-parkinsonian medications, or orthopedic procedures.</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction</b> should be reassessed at each visit and clinical feeding evaluations and/or radiographic swallowing studies should be obtained for choking/gagging during feeds, poor weight gain, frequent respiratory illnesses or feeding refusal that is not otherwise explained. Assuming that the individual is safe to eat by mouth, feeding therapy (typically from an occupational or speech therapist) is recommended to help improve coordination or sensory-related feeding issues. Feeds can be thickened or chilled for safety. When feeding dysfunction is severe, an NG-tube or G-tube may be necessary.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties. An AAC evaluation can be completed by a speech language pathologist who has expertise in the area. The evaluation will consider cognitive abilities and sensory impairments to determine the most appropriate form of communication. AAC devices can range from low-tech, such as picture exchange communication, to high-tech, such as voice-generating devices. Contrary to popular belief, AAC devices do not hinder verbal development of speech and in many cases, can improve it.</p></div><div id="cockayne.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications.</p></div></div><div id="cockayne.Surveillance"><h3>Surveillance</h3><p>Yearly reassessment for known potential complications (e.g., hypertension, renal or hepatic dysfunction, declining vision and hearing) is appropriate [<a class="bk_pop" href="#cockayne.REF.laugel.2013.161">Laugel 2013</a>, <a class="bk_pop" href="#cockayne.REF.wilson.2015.e706">Wilson et al 2015</a>]. See <a class="figpopup" href="/books/NBK1342/table/cockayne.T.recommended_surveillance_for/?report=objectonly" target="object" rid-figpopup="figcockayneTrecommendedsurveillancefor" rid-ob="figobcockayneTrecommendedsurveillancefor">Table 6</a> for specific recommendations.</p><div id="cockayne.T.recommended_surveillance_for" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Cockayne Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1342/table/cockayne.T.recommended_surveillance_for/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cockayne.T.recommended_surveillance_for_lrgtbl__"><table><thead><tr><th id="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Diet</b></td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dietary assessment</td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Biannual</td></tr><tr><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Nervous system</b></td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical review</td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Biannual</td></tr><tr><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eye</b></td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic assessment (evaluation for cataracts &#x00026; retinopathy)</td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annual (biannual until age 4 yrs)</td></tr><tr><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing assessment</td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annual</td></tr><tr><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Diabetes</b></td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Blood glucose</td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annual</td></tr><tr><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Liver</b></td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Liver enzymes</td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annual</td></tr><tr><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Kidney</b></td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Kidney function; uric acid &#x00026; proteinuria</td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annual</td></tr><tr><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Blood pressure</td><td headers="hd_h_cockayne.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annual</td></tr></tbody></table></div></div></div><div id="cockayne.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Excessive sun exposure should be avoided.</p><p>Use of metronidazole should be avoided in any circumstance (risk of severe hepatitis) [<a class="bk_pop" href="#cockayne.REF.wilson.2015.e706">Wilson et al 2015</a>].</p><p>Extra vigilance is needed for opioid and sedative use due to exaggerated response to these types of medications [<a class="bk_pop" href="#cockayne.REF.wilson.2016.483">Wilson et al 2016</a>].</p><p>Growth hormone (GH) levels in individuals with Cockayne syndrome (CS) may be elevated or decreased [<a class="bk_pop" href="#cockayne.REF.park.1994.74">Park et al 1994</a>, <a class="bk_pop" href="#cockayne.REF.hamamy.2005.875">Hamamy et al 2005</a>]. While individuals with CS do not appear to be at increased risk for malignancy (an effect which may be due to simultaneous transcription and cell proliferation deficiency), it is theoretically possible that GH treatment could reverse this compensatory effect and promote tumor growth. Therefore, in the absence of safety and efficacy data, GH treatment cannot be recommended in individuals with CS.</p></div><div id="cockayne.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#cockayne.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cockayne.Pregnancy_Management"><h3>Pregnancy Management</h3><p>No individuals with classic or severe CS (types I or II) have been known to reproduce. A successful (but very difficult) pregnancy has been reported in a young woman with mild CS (type III) [<a class="bk_pop" href="#cockayne.REF.lahiri.2003.871">Lahiri &#x00026; Davies 2003</a>].</p><p>In pregnant women with CS, the limited size of the pelvis and abdomen is the major obstacle to the growth of the fetus and the major threat to pregnancy outcome. Prevention of premature labor and cesarean section under spinal anesthesia are usually needed [<a class="bk_pop" href="#cockayne.REF.lahiri.2003.871">Lahiri &#x00026; Davies 2003</a>, <a class="bk_pop" href="#cockayne.REF.rawlinson.2003.297">Rawlinson &#x00026; Webster 2003</a>].</p></div><div id="cockayne.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="cockayne.Genetic_Counseling"><h2 id="_cockayne_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cockayne.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Cockayne syndrome (CS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="cockayne.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>ERCC6</i> or <i>ERCC8</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Note: Affected sibs will most likely be recognizable as affected within the first few years of life.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Individuals with CS types I or II are not known to reproduce.</div></li><li class="half_rhythm"><div>The offspring of an individual with CS type III are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ERCC6</i> or <i>ERCC8.</i></div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ERCC6</i> or <i>ERCC8</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="cockayne.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>ERCC6</i> or <i>ERCC8</i> pathogenic variants in the family.</p></div><div id="cockayne.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cockayne.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the CS-causing pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cockayne.Resources"><h2 id="_cockayne_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Amy and Friends</b></div><div>OCC The Bowling Green</div><div>Village Road</div><div>Oxton Wirral CH43 5SR</div><div>United Kingdom</div><div><b>Email:</b> info@amyandfriends.org</div><div><a href="https://www.amyandfriends.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.amyandfriends.org</a></div></li><li class="half_rhythm"><div><b>Amy and Friends</b></div><div>Netherlands</div><div><a href="http://www.amyandfriends.nl" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.amyandfriends.nl</a></div></li><li class="half_rhythm"><div><b>Cockayne Syndrome Network</b></div><div>PO Box 282</div><div>Waterford VA 20197</div><div><b>Phone:</b> 703-727-0404; 865-466-4634</div><div><b>Email:</b> cockaynesyndrome@gmail.com</div><div><a href="http://cockaynesyndrome.net" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">cockaynesyndrome.net</a></div></li><li class="half_rhythm"><div><b>L&#x02019;Association Les P&#x02019;tits Bouts</b></div><div>Bergerac 24100</div><div>France</div><div><b>Phone:</b> 06 81 82 28 03</div><div><a href="https://cockayne.fr/lassociation/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cockayne.fr/lassociation</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=cockaynesyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cockayne syndrome</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22190/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cockayne syndrome</a></div></li><li class="half_rhythm"><div><b>Xeroderma Pigmentosum Society, Inc (XP Society)</b></div><div><i>XP Society has material on their site related to UV protection/avoidance.</i></div><div>437 Syndertown Road</div><div>Craryville NY 12521</div><div><b>Phone:</b> 877-XPS-CURE (877-977-2873); 518-851-2612</div><div><b>Email:</b> xps@xps.org</div><div><a href="http://www.xps.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.xps.org</a></div></li><li class="half_rhythm"><div><b>GenIDA (Genetically determined Intellectual Disabilities and Autism Spectrum Disorders) Registry</b></div><div><i>A website for patients, families, and professionals; GenIDA hosts a specific registry for Cockayne syndrome.</i></div><div><b>Email:</b> genida@igbmc.fr</div><div><a href="https://genida.unistra.fr/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.genida.unistra.fr</a></div></li><li class="half_rhythm"><div><b>Myelin Disorders Bioregistry Project</b></div><div><b>Email:</b> myelindisorders@cnmc.org</div><div><a href="https://www.chop.edu/research/myelin-disorders-biorepository-project" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myelin Disorders Bioregistry Project</a></div></li></ul></div><div id="cockayne.Molecular_Genetics"><h2 id="_cockayne_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cockayne.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Cockayne Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1342/table/cockayne.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cockayne.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cockayne.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cockayne.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cockayne.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cockayne.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cockayne.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cockayne.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cockayne.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2074" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ERCC6</i></a></td><td headers="hd_b_cockayne.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2074" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q11<wbr style="display:inline-block"></wbr>​.23</a></td><td headers="hd_b_cockayne.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q03468" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DNA excision repair protein ERCC-6</a></td><td headers="hd_b_cockayne.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ERCC6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ERCC6 database</a></td><td headers="hd_b_cockayne.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ERCC6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ERCC6</a></td><td headers="hd_b_cockayne.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ERCC6[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ERCC6</a></td></tr><tr><td headers="hd_b_cockayne.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1161" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ERCC8</i></a></td><td headers="hd_b_cockayne.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1161" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q12<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cockayne.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q13216" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DNA excision repair protein ERCC-8</a></td><td headers="hd_b_cockayne.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ERCC8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ERCC8 database</a></td><td headers="hd_b_cockayne.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ERCC8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ERCC8</a></td><td headers="hd_b_cockayne.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ERCC8[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ERCC8</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cockayne.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cockayne.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Cockayne Syndrome (<a href="/omim/133540,216400,609412,609413" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1342/table/cockayne.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cockayne.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/133540" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">133540</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COCKAYNE SYNDROME B; CSB</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/216400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">216400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COCKAYNE SYNDROME A; CSA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609412" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609412</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EXCISION REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609413" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609413</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EXCISION REPAIR CROSS-COMPLEMENTING, GROUP 6; ERCC6</td></tr></tbody></table></div></div><div id="cockayne.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The proteins encoded by <i>ERCC6</i> and <i>ERCC8</i> both play important roles in transcription-coupled nucleotide excision repair (TC-NER), a DNA repair process that preferentially removes UV-induced pyrimidine dimers and other transcription-blocking lesions from the transcribed strands of active genes.</p><p><i>ERCC6</i> encodes DNA excision repair protein ERCC-6, which has at least seven domains that are conserved in DNA and RNA helicases. This protein appears to enhance the elongation of transcription products by RNA polymerase II, and possibly also RNA polymerases I and III.</p><p><i>ERCC8</i> encodes DNA excision repair protein ERCC-8, which is a WD-repeat (tryptophan aspartate-repeats) protein component of a large cullin4-mediated E3-ubiquitin ligase complex.</p><p>A deficiency of TC-NER is sufficient to explain the cutaneous photosensitivity of individuals with CS. It is unlikely, however, to explain the growth failure and neurodegeneration that typify CS. In contrast to CS, most individuals with <a href="/books/n/gene/xp/">xeroderma pigmentosum</a> (XP) have normal growth and neurologic function, despite having combined deficiencies of both TC-NER and "global genome nucleotide excision repair" (GG-NER). To explain this apparent paradox, it has been suggested that CS proteins have other functions including roles in transcription reinitiation after genotoxic stress [<a class="bk_pop" href="#cockayne.REF.epanchintsev.2017.1054">Epanchintsev et al 2017</a>], repair of oxidative DNA damage [<a class="bk_pop" href="#cockayne.REF.nardo.2009.6209">Nardo et al 2009</a>, <a class="bk_pop" href="#cockayne.REF.ranes.2016.5246">Ranes et al 2016</a>], and mitochondrial metabolism [<a class="bk_pop" href="#cockayne.REF.kamenisch.2013.270">Kamenisch &#x00026; Berneburg 2013</a>, <a class="bk_pop" href="#cockayne.REF.chatre.2015.e2910">Chatre et al 2015</a>, <a class="bk_pop" href="#cockayne.REF.scheibyeknudsen.2016.12502">Scheibye-Knudsen et al 2016</a>].</p><p><b>Mechanism of disease causation.</b> CS occurs through a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> mechanism.</p><div id="cockayne.T.laboratory_technical_consider" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Laboratory Technical Considerations for Genes Causing Cockayne Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1342/table/cockayne.T.laboratory_technical_consider/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cockayne.T.laboratory_technical_consider_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gene&#x000a0;<sup>1</sup></b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><b>Technical Consideration</b></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC6</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Most variants are predicted <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants. Twenty-two <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been reported to date [<a class="bk_pop" href="#cockayne.REF.calmels.2018.329">Calmels et al 2018</a>].</td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC8</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Most variants are predicted <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants. Thirteen <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been reported to date [<a class="bk_pop" href="#cockayne.REF.calmels.2018.329">Calmels et al 2018</a>].</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cockayne.TF.7.1"><p class="no_margin">Genes in alphabetic order</p></div></dd></dl></div></div></div><div id="cockayne.T.notable_pathogenic_variants_i" class="table"><h3><span class="label">Table 8. </span></h3><div class="caption"><p>Notable Pathogenic Variants in Genes Causing Cockayne Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1342/table/cockayne.T.notable_pathogenic_variants_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cockayne.T.notable_pathogenic_variants_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC6</i></td><td headers="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000124.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000124<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_000115.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000115<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3862C&#x0003e;T</td><td headers="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1288Ter</td><td headers="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Associated w/COFS; <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> in Finnish population [<a class="bk_pop" href="#cockayne.REF.jaakkola.2010.541">Jaakkola et al 2010</a>, <a class="bk_pop" href="#cockayne.REF.laugel.2010.113">Laugel et al 2010</a>]</td></tr><tr><td headers="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC8</i></td><td headers="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000082.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000082<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_000073.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000073<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.966C&#x0003e;A</td><td headers="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr322Ter</td><td headers="hd_h_cockayne.T.notable_pathogenic_variants_i_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Founder variant in Christian Arabs [<a class="bk_pop" href="#cockayne.REF.khayat.2010.3091">Khayat et al 2010</a>, <a class="bk_pop" href="#cockayne.REF.chebly.2018.161">Chebly et al 2018</a>]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="cockayne.TF.8.1"><p class="no_margin">Genes in alphabetic order</p></div></dd></dl></div></div></div></div></div><div id="cockayne.References"><h2 id="_cockayne_References_">References</h2><div id="cockayne.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.baez.2013.80">Baez S, Couto B, Herrera E, Bocanegra Y, Trujillo-Orrego N, Madrigal-Zapata L, Cardona JF, Manes F, Ibanez A, Villegas A. Tracking the cognitive, social, and neuroanatomical profile in early neurodegeneration: Type III Cockayne syndrome. <span><span class="ref-journal">Front Aging Neurosci. </span>2013;<span class="ref-vol">5</span>:80.</span> [<a href="/pmc/articles/PMC3840614/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3840614</span></a>] [<a href="/pubmed/24324434" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24324434</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.blochzupan.2013.9">Bloch-Zupan A, Rousseaux M, Laugel-Haushalter V, Schmittbuhl M, Mathis R, Desforges E, Koob M, Zaloszyc A, Dollfus H, Laugel V. A possible cranio-oro-facial phenotype in Cockayne syndrome. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2013;<span class="ref-vol">8</span>:9.</span> [<a href="/pmc/articles/PMC3599377/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3599377</span></a>] [<a href="/pubmed/23311583" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23311583</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.calmels.2018.329">Calmels N, Botta E, Jia N, Fawcett H, Nardo T, Nakazawa Y, Lanzafame M, Moriwaki S, Sugita K, Kubota M, Obringer C, Spitz MA, Stefanini M, Laugel V, Orioli D, Ogi T, Lehmann A. Functional and clinical relevance of novel mutations in a large cohort of patients with Cockayne syndrome. <span><span class="ref-journal">J Med Genet. </span>2018;<span class="ref-vol">55</span>:329–43.</span> [<a href="/pubmed/29572252" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29572252</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.chatre.2015.e2910">Chatre L, Biard DS, Sarasin A, Ricchetti M. Reversal of mitochondrial defects with CSB-dependent serine protease inhibitors in patient cells of the progeroid Cockayne syndrome. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2015;<span class="ref-vol">112</span>:E2910–9.</span> [<a href="/pmc/articles/PMC4460464/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4460464</span></a>] [<a href="/pubmed/26038566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26038566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.chebly.2018.161">Chebly A, Corbani S, Abou Ghoch J, Mehawej C, Megarbane A, Chouery E. First molecular study in Lebanese patients with Cockayne syndrome and report of a novel mutation in ERCC8 gene. <span><span class="ref-journal">BMC Med Genet. </span>2018;<span class="ref-vol">19</span>:161.</span> [<a href="/pmc/articles/PMC6131905/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6131905</span></a>] [<a href="/pubmed/30200888" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30200888</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.epanchintsev.2017.1054">Epanchintsev A, Costanzo F, Rauschendorf MA, Caputo M, Ye T, Donnio LM, Proietti-de-Santis L, Coin F, Laugel V, Egly JM. Cockayne's Syndrome A and B Proteins Regulate Transcription Arrest after Genotoxic Stress by Promoting ATF3 Degradation. <span><span class="ref-journal">Mol Cell. </span>2017;<span class="ref-vol">68</span>:1054–66.e6.</span> [<a href="/pubmed/29225035" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29225035</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.frouin.2013.1414">Frouin E, Laugel V, Durand M, Dollfus H, Lipsker D. Dermatologic findings in 16 patients with Cockayne syndrome and cerebro-oculo-facial-skeletal syndrome. <span><span class="ref-journal">JAMA Dermatol. </span>2013;<span class="ref-vol">149</span>:1414–8.</span> [<a href="/pubmed/24154677" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24154677</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.graham.2004.235">Graham JM Jr, Hennekam R, Dobyns WB, Roeder E, Busch D. MICRO syndrome: an entity distinct from COFS syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">128A</span>:235–45.</span> [<a href="/pubmed/15216543" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15216543</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.hamamy.2005.875">Hamamy HA, Daas HA, Shegem NS, Al-Hadidy AM, Ajlouni K. Cockayne syndrome in 2 siblings. <span><span class="ref-journal">Saudi Med J. </span>2005;<span class="ref-vol">26</span>:875–9.</span> [<a href="/pubmed/15951889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15951889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.hayashi.2012.113">Hayashi M, Miwa-Saito N, Tanuma N, Kubota M. Brain vascular changes in Cockayne syndrome. <span><span class="ref-journal">Neuropathology. </span>2012;<span class="ref-vol">32</span>:113–7.</span> [<a href="/pubmed/21749465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21749465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.horibata.2004.15410">Horibata K, Iwamoto Y, Kuraoka I, Jaspers NG, Kurimasa A, Oshimura M, Ichihashi M, Tanaka K. Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2004;<span class="ref-vol">101</span>:15410–5.</span> [<a href="/pmc/articles/PMC524447/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC524447</span></a>] [<a href="/pubmed/15486090" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15486090</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.jaakkola.2010.541">Jaakkola E, Mustonen A, Olsen P, Miettinen S, Savuoja T, Raams A, Jaspers NG, Shao H, Wu BL, Ignatius J. ERCC6 founder mutation identified in Finnish patients with COFS syndrome. <span><span class="ref-journal">Clin Genet. </span>2010;<span class="ref-vol">78</span>:541–7.</span> [<a href="/pubmed/20456449" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20456449</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.kamenisch.2013.270">Kamenisch Y, Berneburg M. Mitochondrial CSA and CSB: protein interactions and protection from ageing associated DNA mutations. <span><span class="ref-journal">Mech Ageing Dev. </span>2013;<span class="ref-vol">134</span>:270–4.</span> [<a href="/pubmed/23562423" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23562423</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.khayat.2010.3091">Khayat M, Hardouf H, Zlotogora J, Shalev SA. High carriers frequency of an apparently ancient founder mutation p.Tyr322X in the ERCC8 gene responsible for Cockayne syndrome among Christian Arabs in Northern Israel. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:3091–4.</span> [<a href="/pubmed/21108394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21108394</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.kleijer.2008.744">Kleijer WJ, Laugel V, Berneburg M, Nardo T, Fawcett H, Gratchev A, Jaspers NG, Sarasin A, Stefanini M, Lehmann AR. Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. <span><span class="ref-journal">DNA Repair (Amst). </span>2008;<span class="ref-vol">7</span>:744–50.</span> [<a href="/pubmed/18329345" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18329345</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.koob.2010.1623">Koob M, Laugel V, Durand M, Fothergill H, Dalloz C, Sauvanaud F, Dollfus H, Namer IJ, Dietemann JL. Neuroimaging in Cockayne syndrome. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2010;<span class="ref-vol">31</span>:1623–30.</span> [<a href="/pubmed/20522568" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20522568</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.koob.2016.20151033">Koob M, Rousseau F, Laugel V, Meyer N, Armspach JP, Girard N, Dietemann JL. Cockayne syndrome: a diffusion tensor imaging and volumetric study. <span><span class="ref-journal">Br J Radiol. </span>2016;<span class="ref-vol">89</span>:20151033.</span> [<a href="/pmc/articles/PMC5124826/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5124826</span></a>] [<a href="/pubmed/27643390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27643390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.lahiri.2003.871">Lahiri S, Davies N. Cockayne's Syndrome: case report of a successful pregnancy. <span><span class="ref-journal">BJOG. </span>2003;<span class="ref-vol">110</span>:871–2.</span> [<a href="/pubmed/14511973" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14511973</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.laugel.2013.161">Laugel V. Cockayne syndrome: the expanding clinical and mutational spectrum. <span><span class="ref-journal">Mech Ageing Dev. </span>2013;<span class="ref-vol">134</span>:161–70.</span> [<a href="/pubmed/23428416" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428416</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.laugel.2010.113">Laugel V, Dalloz C, Durand M, Sauvanaud F, Kristensen U, Vincent MC, Pasquier L, Odent S, Cormier-Daire V, Gener B, Tobias ES, Tolmie JL, Martin-Coignard D, Drouin-Garraud V, Heron D, Journel H, Raffo E, Vigneron J, Lyonnet S, Murday V, Gubser-Mercati D, Funalot B, Brueton L, Sanchez Del Pozo J, Mu&#x000f1;oz E, Gennery AR, Salih M, Noruzinia M, Prescott K, Ramos L, Stark Z, Fieggen K, Chabrol B, Sarda P, Edery P, Bloch-Zupan A, Fawcett H, Pham D, Egly JM, Lehmann AR, Sarasin A, Dollfus H. Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:113–26.</span> [<a href="/pubmed/19894250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19894250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.laugel.2008.564">Laugel V, Dalloz C, Tobias ES, Tolmie JL, Martin-Coignard D, Drouin-Garraud V, Valayannopoulos V, Sarasin A, Dollfus H. Cerebro-oculo-facio-skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation. <span><span class="ref-journal">J Med Genet. </span>2008;<span class="ref-vol">45</span>:564–71.</span> [<a href="/pubmed/18628313" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18628313</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.nakazawa.2010.506">Nakazawa Y, Yamashita S, Lehmann AR, Ogi T. A semi-automated non-radioactive system for measuring recovery of RNA synthesis and unscheduled DNA synthesis using ethynyluracil derivatives. <span><span class="ref-journal">DNA Repair (Amst). </span>2010;<span class="ref-vol">9</span>:506–16.</span> [<a href="/pubmed/20171149" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20171149</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.nance.1992.68">Nance MA, Berry SA. Cockayne syndrome: review of 140 cases. <span><span class="ref-journal">Am J Med Genet. </span>1992;<span class="ref-vol">42</span>:68–84.</span> [<a href="/pubmed/1308368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1308368</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.nardo.2009.6209">Nardo T, Oneda R, Spivak G, Vaz B, Mortier L, Thomas P, Orioli D, Laugel V, Stary A, Hanawalt PC, Sarasin A, Stefanini M. A UV-sensitive syndrome patient with a specific CSA mutation reveals separable roles for CSA in response to UV and oxidative DNA damage. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2009;<span class="ref-vol">106</span>:6209–14.</span> [<a href="/pmc/articles/PMC2667150/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2667150</span></a>] [<a href="/pubmed/19329487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19329487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.natale.2011.1081">Natale V. A comprehensive description of the severity groups in Cockayne syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:1081–95.</span> [<a href="/pubmed/21480477" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21480477</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.neilan.2008.1117">Neilan EG, Delgado MR, Donovan MA, Kim SY, Jou RL, Wu BL, Kang PB. Response of motor complications in Cockayne syndrome to carbidopa-levodopa. <span><span class="ref-journal">Arch Neurol. </span>2008;<span class="ref-vol">65</span>:1117–21.</span> [<a href="/pubmed/18695064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18695064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.park.1994.74">Park SK, Chang SH, Cho SB, Baek HS, Lee DY. Cockayne syndrome: a case with hyperinsulinemia and growth hormone deficiency. <span><span class="ref-journal">J Korean Med Sci. </span>1994;<span class="ref-vol">9</span>:74–7.</span> [<a href="/pmc/articles/PMC3053904/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3053904</span></a>] [<a href="/pubmed/8068222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8068222</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.pena.1974.285">Pena SD, Shokeir MH. Autosomal recessive cerebro-oculo-facio-skeletal (COFS) syndrome. <span><span class="ref-journal">Clin Genet. </span>1974;<span class="ref-vol">5</span>:285–93.</span> [<a href="/pubmed/4211825" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4211825</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.qin.2015.e1005419">Qin Y, Guo T, Li G, Tang TS, Zhao S, Jiao X, Gong J, Gao F, Guo C, Simpson JL, Chen ZJ. CSB-PGBD3 Mutations Cause Premature Ovarian Failure. <span><span class="ref-journal">PLoS Genet. </span>2015;<span class="ref-vol">11</span>:e1005419.</span> [<a href="/pmc/articles/PMC4517778/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4517778</span></a>] [<a href="/pubmed/26218421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26218421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.ranes.2016.5246">Ranes M, Boeing S, Wang Y, Wienholz F, Menoni H, Walker J, Encheva V, Chakravarty P, Mari PO, Stewart A, Giglia-Mari G, Snijders AP, Vermeulen W, Svejstrup JQ. A ubiquitylation site in Cockayne syndrome B required for repair of oxidative DNA damage, but not for transcription-coupled nucleotide excision repair. <span><span class="ref-journal">Nucleic Acids Res. </span>2016;<span class="ref-vol">44</span>:5246–55.</span> [<a href="/pmc/articles/PMC4914099/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4914099</span></a>] [<a href="/pubmed/27060134" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27060134</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.rawlinson.2003.297">Rawlinson SC, Webster VJ. Spinal anaesthesia for caesarean section in a patient with Cockayne syndrome. <span><span class="ref-journal">Int J Obstet Anesth. </span>2003;<span class="ref-vol">12</span>:297–9.</span> [<a href="/pubmed/15321464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15321464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.scheibyeknudsen.2016.12502">Scheibye-Knudsen M, Tseng A, Borch Jensen M, Scheibye-Alsing K, Fang EF, Iyama T, Bharti SK, Marosi K, Froetscher L, Kassahun H, Eckley DM, Maul RW, Bastian P, De S, Ghosh S, Nilsen H, Goldberg IG, Mattson MP, Wilson DM 3rd, Brosh RM Jr, Gorospe M, Bohr VA. Cockayne syndrome group A and B proteins converge on transcription-linked resolution of non-B DNA. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2016;<span class="ref-vol">113</span>:12502–7.</span> [<a href="/pmc/articles/PMC5098674/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5098674</span></a>] [<a href="/pubmed/27791127" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27791127</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.sterndelfils.2019">Stern-Delfils A, Spitz MA, Durand M, Obringer C, Calmels N, Olagne J, Pillay K, Fieggen K, Laugel V, Zaloszyc A. Renal disease in Cockayne syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2019.</span> Epub ahead of print. [<a href="/pubmed/30630117" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30630117</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.van_wyhe.2018.64">Van Wyhe RD, Emery CV, Williamson RA. Cochlear implantation in pediatric patients with Cockayne Syndrome. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2018;<span class="ref-vol">106</span>:64–67.</span> [<a href="/pubmed/29447894" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29447894</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.weidenheim.2009.619">Weidenheim KM, Dickson DW, Rapin I. Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration. <span><span class="ref-journal">Mech Ageing Dev. </span>2009;<span class="ref-vol">130</span>:619–36.</span> [<a href="/pubmed/19647012" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19647012</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.wilson.2016.483">Wilson BT, Stark Z, Sutton RE, Danda S, Ekbote AV, Elsayed SM, Gibson L, Goodship JA, Jackson AP, Keng WT, King MD, McCann E, Motojima T, Murray JE, Omata T, Pilz D, Pope K, Sugita K, White SM, Wilson IJ. The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for care. <span><span class="ref-journal">Genet Med. </span>2016;<span class="ref-vol">18</span>:483–93.</span> [<a href="/pmc/articles/PMC4857186/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4857186</span></a>] [<a href="/pubmed/26204423" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26204423</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cockayne.REF.wilson.2015.e706">Wilson BT, Strong A, O'Kelly S, Munkley J, Stark Z. Metronidazole toxicity in Cockayne syndrome: a case series. <span><span class="ref-journal">Pediatrics. </span>2015;<span class="ref-vol">136</span>:e706–8.</span> [<a href="/pubmed/26304821" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26304821</span></a>]</div></li></ul></div></div><div id="cockayne.Chapter_Notes"><h2 id="_cockayne_Chapter_Notes_">Chapter Notes</h2><div id="cockayne.Author_History"><h3>Author History</h3><p>Vincent Laugel, MD, PhD (2012-present)<br />Martha A Nance, MD; Park Nicollet Clinic (2000-2006) <br />Edward G Neilan, MD, PhD; Children's Hospital Boston (2006-2012)</p></div><div id="cockayne.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>29 August 2019 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>14 June 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 March 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 September 2003 (cd) Revision: clinical test no longer available</div></li><li class="half_rhythm"><div>21 August 2003 (cd) Revision: change in <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> name</div></li><li class="half_rhythm"><div>31 July 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 October 2001 (mn) Author revision</div></li><li class="half_rhythm"><div>28 December 2000 (me) Review posted live</div></li><li class="half_rhythm"><div>June 2000 (mn) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1342</span><span class="label">PMID: <a href="/pubmed/20301516" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301516</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ccd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cls/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1342&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1342/?report=reader">PubReader</a></li><li><a href="/books/NBK1342/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1342" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1342" style="display:none" title="Cite this Page"><div class="bk_tt">Laugel V. Cockayne Syndrome. 2000 Dec 28 [Updated 2019 Aug 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1342/pdf/Bookshelf_NBK1342.pdf">PDF version of this page</a> (490K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cockayne.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cockayne.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#cockayne.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cockayne.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cockayne.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cockayne.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cockayne.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cockayne.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cockayne.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cockayne.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cockayne.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cockayne.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1161[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ERCC8</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2074[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ERCC6</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1478872" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1478872" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1478872" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1478872" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301444" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alström Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alström Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Paisey RB, Steeds R, Barrett T, Williams D, Geberhiwot T, Gunay-Aygun M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23844448" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type IVA</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type IVA<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Regier DS, Oetgen M, Tanpaiboon P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301341" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Clarke LA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31145570" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wenger TL, Hing AV, Evans KN. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301653" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lowe Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lowe Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lewis RA, Nussbaum RL, Brewer ED. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301516" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301516" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04171d39a66ee2ba27bcac">Cockayne Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Cockayne Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:12:45-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88B316E04075D10000000006B10295&amp;ncbi_session=CE88B316E04171C1_1713SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1342%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1342&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1342/&amp;ncbi_pagename=Cockayne Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88B316E04171C1_1713SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>